MDxHealth (MDXH) said Monday it expects Q4 revenue to increase by 28% year over year to about $24.7 million.
Five analysts polled by FactSet expect $23 million.
For 2024, the company also projected a 28% revenue growth to $90 million. Analysts surveyed by FactSet expect $87.9 million.
In addition, MDxHealth said it expects 2025 revenue growth of 20% to 22% to between $108 million and $110 million and reiterated its forecast of adjusted EBITDA profitability in H1.
Shares of MDxHealth were up more than 10% in recent premarket activity Monday.
Price: 2.18, Change: +0.20, Percent Change: +10.10
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.